EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Intestinal neutrophil extracellular traps promote gut barrier damage exacerbating endotoxaemia, systemic inflammation and progression of diabetic retinopathy in type 2 diabetes

Jason L Floyd, Ram Prasad, Mariana D Dupont, Yvonne Adu-Rutledge, Shambhavi Anshumali, Sarbodeep Paul, Sergio Li Calzi, Xiaoping Qi, Akanksha Malepati, Emory Johnson, Patricia Jumbo-Lucioni, Jason N Crosson und 4 weitere

Diabetologia · 2025

DOI: 10.1007/s00125-024-06349-4 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Diabetologia, 2025. Verfasst von Jason L Floyd und 15 weiteren Autor:innen. Beteiligte Einrichtung: Department of Ophthalmology and Visual Sciences, Heersink School of Medicine, University of Alabama at Birmingham, Birmingham, AL, USA. Hauptthemen laut MEDLINE: Diabetic Retinopathy, Diabetes Mellitus, Type 2, Extracellular Traps, Endotoxemia. Die Arbeit wurde bisher 24-mal zitiert (Crossref) und nennt 75 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: NIDDK NIH HHS, NEI NIH HHS, NHLBI NIH HHS.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Aims/hypothesis Within the small intestine, neutrophils play an integral role in preventing bacterial infection. Upon interaction with bacteria or bacteria-derived antigens, neutrophils initiate a multi-staged response of which the terminal stage is NETosis, formation of protease-decorated nuclear DNA into extracellular traps. NETosis has a great propensity to elicit ocular damage and has been associated with diabetic retinopathy and diabetic macular oedema (DME) progression. Here, we interrogate the relationship between gut barrier dysfunction, endotoxaemia and systemic and intestinal neutrophilia in diabetic retinopathy.

Methods

In a cohort of individuals with type 2 diabetes ( n =58) with varying severity of diabetic retinopathy and DME, we characterised the abundance of circulating neutrophils by flow cytometry and markers of gut permeability and endotoxaemia by plasma ELISA. In a mouse model of type 2 diabetes, we examined the effects of diabetes on abundance and function of intestinal, blood and bone marrow neutrophils, gut barrier integrity, endotoxaemia and diabetic retinopathy severity. Pharmacological inhibition of NETosis was achieved by i.p. injection of the peptidyl arginine deiminase 4 inhibitor (PAD4i) GSK484 daily for 4 weeks between 6 and 7 months of type 2 diabetes.

Results

In human participants, neutrophilia was unique to individuals with type 2 diabetes with diabetic retinopathy and DME and was accompanied by heightened circulating markers of gut permeability. At late-stage diabetes, neutrophilia and gut barrier dysfunction were seen in db/db mice. The db/db mice exhibited an increase in stem-like pre-neutrophils in the intestine and bone marrow and a decrease in haematopoietic vascular reparative cells. In the db/db mouse intestine, enhanced loss of gut barrier integrity was associated with elevated intestinal NETosis. Inhibition of NETosis by the PAD4i GSK484 resulted in decreased abundance of premature neutrophils in the intestine and blood and resulted in neutrophil retention in the bone marrow compared with vehicle-treated db/db mice. Additionally, the PAD4i decreased senescence within the gut epithelium and yielded a slowing of diabetic retinopathy progression. Conclusions/interpretation Severity of diabetic retinopathy and DME were associated with peripheral neutrophilia, gut barrier dysfunction and endotoxaemia in the human participants. db/db mice exhibited intestinal neutrophilia, specifically stem-like pre-neutrophils, which was associated with elevated NETosis and decreased levels of vascular reparative cells. Chronic inhibition of NETosis in db/db mice reduced intestinal senescence and NETs in the retina. These changes were associated with reduced endotoxaemia and an anti-inflammatory bone marrow milieu with retention of pre-neutrophils in the bone marrow and increased gut infiltration of myeloid angiogenic cells. Collectively, PAD-4i treatment decreased gut barrier dysfunction, restoring physiological haematopoiesis and levels of haematopoietic vascular reparative cells. Graphical Abstract

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Diabetic RetinopathyDiabetes Mellitus, Type 2Extracellular TrapsEndotoxemiaNeutrophilsInflammationAnimalsHumansMiceMaleFemaleMiddle AgedDisease ProgressionMice, Inbred C57BLIntestinal MucosaAged

Stichwörter der Autor:innen

DiabetesDiabetic retinopathyGut permeabilityNETosisNeutrophilPAD4

Autor:innen und Institutionen

  • Department of Ophthalmology and Visual Sciences, Heersink School of Medicine, University of Alabama at Birmingham, Birmingham, AL, USA.
  • Pharmaceutical, Social and Administrative Sciences, Samford University, Birmingham, AL, USA.
  • Retina Consultants of Alabama, Birmingham, AL, USA.
  • Department of Medicine, Division Hematology/Oncology, Heersink School of Medicine, University of Alabama at Birmingham, Birmingham, AL, USA.
  • Department of Ophthalmology and Visual Sciences, Heersink School of Medicine, University of Alabama at Birmingham, Birmingham, AL, USA. mariagrant@uabmc.edu.

Förderung

  • NIDDK NIH HHS
  • NEI NIH HHS
  • NHLBI NIH HHS
  • Research to Prevent Blindness
  • NCRR NIH HHS
  • National Eye Institute
  • National Institute of Diabetes and Digestive and Kidney Diseases
  • National Heart, Lung, and Blood Institute

Zitieren

APA

Floyd, J. L., Prasad, R., Dupont, M. D., Adu-Rutledge, Y., Anshumali, S., Paul, S., Li Calzi, S., Qi, X., Malepati, A., Johnson, E., Jumbo-Lucioni, P., Crosson, J. N., Mason, J. O., Boulton, M. E., Welner, R. S., & Grant, M. B. (2025). Intestinal neutrophil extracellular traps promote gut barrier damage exacerbating endotoxaemia, systemic inflammation and progression of diabetic retinopathy in type 2 diabetes. Diabetologia. https://doi.org/10.1007/s00125-024-06349-4

Vancouver

Floyd JL, Prasad R, Dupont MD, Adu-Rutledge Y, Anshumali S, Paul S, et al. Intestinal neutrophil extracellular traps promote gut barrier damage exacerbating endotoxaemia, systemic inflammation and progression of diabetic retinopathy in type 2 diabetes. Diabetologia. 2025. doi:10.1007/s00125-024-06349-4

BibTeX
@article{Floyd2025,
  author = {Floyd, Jason L and Prasad, Ram and Dupont, Mariana D and Adu-Rutledge, Yvonne and Anshumali, Shambhavi and Paul, Sarbodeep and Li Calzi, Sergio and Qi, Xiaoping and Malepati, Akanksha and Johnson, Emory and Jumbo-Lucioni, Patricia and Crosson, Jason N and Mason, John O and Boulton, Michael E and Welner, Robert S and Grant, Maria B},
  title = {Intestinal neutrophil extracellular traps promote gut barrier damage exacerbating endotoxaemia, systemic inflammation and progression of diabetic retinopathy in type 2 diabetes},
  journal = {Diabetologia},
  year = {2025},
  doi = {10.1007/s00125-024-06349-4}
}
Kostenlos starten →